Merck KGaA R&D Update Call Transcript
Dear ladies and gentlemen, welcome to the Merck R&D update call. (Operator Instructions) May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.
Thank you very much, Heidi. Dear ladies and gentlemen, a very warm welcome to this Merck 2022 Healthcare R&D Update Call.
My name is Constantin Fest, I'm Head of Investor Relations at Merck. And I'm delighted to be joined today by the following presenters. We have Danny Bar-Zohar, Global Head of Research and Development and Chief Medical Officer; Klaus Urbahns, Global Head of Discovery and Development Technologies; Victoria Zazulina, Global Head of Development Unit Oncology; and Jan Klatt, Global Head of Development Unit Neurology & Immunology. Please note, also joining for the Q&A part of this call is Andrew Paterson, Chief Marketing Officer.
In the next 50 to 60 minutes, we'd like to run you through the key slides of this presentation,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
